1.3.1.2: dihydropyrimidine dehydrogenase (NADP+)
This is an abbreviated version!
For detailed information about dihydropyrimidine dehydrogenase (NADP+), go to the full flat file.
Word Map on EC 1.3.1.2
-
1.3.1.2
-
5-fluorouracil
-
thymidine
-
phosphorylase
-
uridine
-
medicine
-
phosphoribosyltransferase
-
orotate
-
2.4.2.4
-
thymidylate
-
fluoropyrimidine
-
fdurd
-
2.7.1.21
-
beta-ureidopropionase
-
urdpase
-
dihydropyrimidinase
-
beta-alanine
-
drug development
-
analysis
- 1.3.1.2
- 5-fluorouracil
- thymidine
- phosphorylase
- uridine
- medicine
-
phosphoribosyltransferase
- orotate
-
2.4.2.4
- thymidylate
-
fluoropyrimidine
-
fdurd
-
2.7.1.21
- beta-ureidopropionase
- urdpase
- dihydropyrimidinase
- beta-alanine
- drug development
- analysis
Reaction
Synonyms
4,5-dihydrothymine: oxidoreductase, dehydrogenase, dihydrouracil (nicotinamide adenine dinucleotide phosphate), DHPDH, DHPDHase, DHU dehydrogenase, dihydropyrimidine dehydrogenase, dihydrothymine dehydrogenase, Dihydrouracil dehydrogenase, dihydrouracil dehydrogenase (NADP), dihydrouracil dehydrogenase (NADP+), DPD, DPYD, hydropyrimidine dehydrogenase
ECTree
1.3.1.2 dihydropyrimidine dehydrogenase (NADP+)Advanced search results
results (
results (Substrates Products
Substrates Products on EC 1.3.1.2 - dihydropyrimidine dehydrogenase (NADP+)
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
top
SUBSTRATE 
PRODUCT
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate)
(Substrate)
LITERATURE
(Substrate)
(Substrate)
COMMENTARY
(Product)
(Product)
LITERATURE
(Product)
(Product)
Reversibility
r=reversible
ir=irreversible
?=not specified
r=reversible
ir=irreversible
?=not specified
5,6-dihydrouracil + NADP+
uracil + NADPH
-
first and rate-limiting enzyme in the three-step pathway for the degradation of uracil
-
-
?
5,6-dihydrouracil + NADP+
uracil + NADPH
-
first and rate-limiting enzyme in the three-step pathway for the degradation of uracil
-
-
?
5,6-dihydrouracil + NADP+
uracil + NADPH
-
first and rate-limiting enzyme in the three-step pathway for the degradation of uracil
-
-
?
5,6-dihydrouracil + NADP+
uracil + NADPH
-
reversibility of the reaction only in vitro
-
r
5,6-dihydrouracil + NADP+
uracil + NADPH
-
first and rate-limiting enzyme in the three-step pathway for the degradation of uracil
-
-
?
5,6-dihydrouracil + NADP+
uracil + NADPH
-
C671A mutant only forms complex with dihydrouracil nearly without oxidizing it
-
r
5,6-dihydrouracil + NADP+
uracil + NADPH
-
first and rate-limiting enzyme in the three-step pathway for the degradation of uracil
-
-
?
5-fluorouracil + NADPH + H+
5-fluoro-5,6-dihydrouracil + NADP+
-
-
-
-
?
5-iodouracil + NADPH
5-iodo-5,6-dihydrouracil + NADP+
-
-
alkylating and therefore in vivo inactivating product
?
dihydrofluorouracil + NADP+
5-fluorouracil + NADPH + H+
-
-
dihydrofluorouracil is further metabolized to 2'-fluoro-beta-alanine
-
?
dihydrofluorouracil + NADP+
5-fluorouracil + NADPH + H+
-
development of a detection method using 2'-fluoro-beta-alanine derivatization with o-phthalaldehyde at room temperature and mass spectrometric analysis by the liquid chromatography-mass spectrometry-electrospray ionization system, method evaluation and optimization, overview
dihydrofluorouracil is further metabolized to 2'-fluoro-beta-alanine
-
?
dihydrofluorouracil + NADP+
5-fluorouracil + NADPH + H+
dihydrofluorouracil is further metabolized to 2'-fluoro-beta-alanine
-
-
?
dihydrofluorouracil + NADP+
5-fluorouracil + NADPH + H+
pyrimidine binding to this enzyme is accompanied by active site loop closure that positions a catalytically crucial cysteine 671 residue. The deprotonation of the loop residue H673 is required for active site closure, while S670 is important for substrate recognition. R235 is crucial for FAD binding
dihydrofluorouracil is further metabolized to 2'-fluoro-beta-alanine
-
?
thymine + NADPH
dihydrothymine + NADP+
-
rate-limiting enzyme in catabolic detoxification of exogenous fluoropyrimidines
-
?
thymine + NADPH
dihydrothymine + NADP+
-
rate-limiting enzyme in catabolic detoxification of exogenous fluoropyrimidines
-
?
thymine + NADPH
dihydrothymine + NADP+
-
rate-limiting enzyme in catabolic detoxification of exogenous fluoropyrimidines
-
?
thymine + NADPH
dihydrothymine + NADP+
-
rate-limiting enzyme in catabolic detoxification of exogenous fluoropyrimidines
-
?
thymine + NADPH
dihydrothymine + NADP+
-
rate-limiting enzyme of thymidine and uridine degradation
-
?
thymine + NADPH
dihydrothymine + NADP+
-
rate-limiting enzyme of thymidine and uridine degradation
-
r
uracil + NADPH
5,6-dihydrouracil + NADP+
-
rate limiting enzyme in pyrimidine degradation
-
?
uracil + NADPH
5,6-dihydrouracil + NADP+
-
rate limiting step in catabolic breakdown of uracil to beta-alanine
-
?
uracil + NADPH
5,6-dihydrouracil + NADP+
-
rate limiting enzyme in pyrimidine degradation
-
?
uracil + NADPH
5,6-dihydrouracil + NADP+
-
rate limiting enzyme in pyrimidine degradation
-
-
?
uracil + NADPH
5,6-dihydrouracil + NADP+
-
reversibility of the reaction only in vitro
-
r
uracil + NADPH
5,6-dihydrouracil + NADP+
-
rate limiting step in catabolic breakdown of uracil to beta-alanine
-
r
uracil + NADPH
5,6-dihydrouracil + NADP+
-
rate limiting step in catabolic breakdown of uracil to beta-alanine
-
r
uracil + NADPH
5,6-dihydrouracil + NADP+
-
rate limiting enzyme in pyrimidine degradation
-
?
uracil + NADPH
5,6-dihydrouracil + NADP+
-
rate limiting enzyme in pyrimidine degradation
-
r
uracil + NADPH
5,6-dihydrouracil + NADP+
-
rate limiting enzyme in pyrimidine degradation
-
?
uracil + NADPH
5,6-dihydrouracil + NADP+
-
rate limiting enzyme in pyrimidine degradation
-
?
additional information
?
-
the first FeS cluster, with unusual coordination, cannot be reduced and displays no activity when Q156 is mutated to glutamate. The active site loop comprising residues 670-683 are observed in open and closed conformational states, overview
-
-
?
